These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Epidemiology and treatment of long-term male impotence]. Andriani E; Cosentina R Minerva Cardioangiol; 1996 May; 44(5):237-42. PubMed ID: 8927252 [TBL] [Abstract][Full Text] [Related]
65. Drugs for impotence. McGuffey E; Kramer L Am Pharm; 1992 Dec; NS32(12):23. PubMed ID: 1285547 [No Abstract] [Full Text] [Related]
66. A study in patients with erectile dysfunction comparing different formulations of prostaglandin E1. Alprostadil Study Group. Vanderschueren D; Heyrman RM; Keogh EJ; Casey RW; Weiske WH; Ogrinc FG; de Koning Gans HJ J Urol; 1995 Nov; 154(5):1744-7. PubMed ID: 7563337 [TBL] [Abstract][Full Text] [Related]
67. Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs. Rodriguez Antolin A; Morales JM; Andrés A; Fernández Aparicio T; Díaz González R; Pamplona M; Alvarez E Transplant Proc; 1992 Feb; 24(1):105-6. PubMed ID: 1539195 [No Abstract] [Full Text] [Related]
68. [The therapeutic efficacy for ED patients treated with low dosage of PGE1]. Zhao D; Zhang B; Ou RB; Liao B; Chen YX; Lu AH; Wan ST; Lu MQ Zhonghua Nan Ke Xue; 2003 Feb; 9(1):48-50. PubMed ID: 12680333 [TBL] [Abstract][Full Text] [Related]
69. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. Hellstrom WJ; Lewis RW J Urol; 1999 Oct; 162(4):1390. PubMed ID: 10492215 [No Abstract] [Full Text] [Related]
70. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. Subramonian K; Weston PM J Urol; 1999 Jul; 162(1):168-9. PubMed ID: 10379774 [No Abstract] [Full Text] [Related]
71. Intracavernous injections for impotence. Med Lett Drugs Ther; 1990 Dec; 32(834):116-7. PubMed ID: 2255296 [No Abstract] [Full Text] [Related]
72. Penile rigidity in erectile dysfunction treated with alprostadil. Greco E; Polonio-Balbi P Lancet; 1997 Dec; 350(9092):1682. PubMed ID: 9400524 [No Abstract] [Full Text] [Related]
73. Comparative tolerability and efficacy of treatments for impotence. Meinhardt W; Kropman RF; Vermeij P Drug Saf; 1999 Feb; 20(2):133-46. PubMed ID: 10082071 [TBL] [Abstract][Full Text] [Related]
74. Pharmacotherpay of sexual impotence in the male. Benkert O Mod Probl Pharmacopsychiatry; 1980; 15():158-73. PubMed ID: 6999332 [No Abstract] [Full Text] [Related]
75. From the Food and Drug Administration. Nightingale SL JAMA; 1995 Sep; 274(12):935. PubMed ID: 7674512 [No Abstract] [Full Text] [Related]
76. PNU-83757: a new agent for the treatment of erectile dysfunction. Carson CC Curr Urol Rep; 2002 Dec; 3(6):465-6. PubMed ID: 12425868 [No Abstract] [Full Text] [Related]
78. Re: International Journal of Impotence Research 1998; 10: 61-62. Ghanem HM Int J Impot Res; 1998 Dec; 10(4):261. PubMed ID: 9884925 [No Abstract] [Full Text] [Related]
79. Recent advances in the role of pharmaceutical agents in impotence. Keogh EJ; Earle CM Reprod Fertil Dev; 1989; 1(4):387-90. PubMed ID: 2699938 [No Abstract] [Full Text] [Related]